News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ZANTE GREG
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| ZANTE GREG (CFO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 131,029 shares
@ $17.0025, valued at
$2.2M
Sold 30,911 shares
@ $18, valued at
$556.4k
Granted 56,667 shares
@ $0
Paid exercise price by delivering 55,166 shares
@ $17.57, valued at
$969.3k
Exercised 32,000 options to buy
@ $8.52, valued at
$272.6k
Exercised 42,000 options to buy
@ $7.69, valued at
$323k
Exercised 12,250 options to buy
@ $4.65, valued at
$57k
Exercised 7,500 options to buy
@ $4.12, valued at
$30.9k
Exercised 30,911 options to buy
@ $7.77, valued at
$240.2k
|
|
| 01/04/2023 |
4
| ZANTE GREG (CFO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 20,233 shares
@ $0
Paid exercise price by delivering 19,697 shares
@ $9.4, valued at
$185.2k
Granted 90,667 shares
@ $0
Paid exercise price by delivering 23,933 shares
@ $8.52, valued at
$203.9k
Paid exercise price by delivering 20,708 shares
@ $8.42, valued at
$174.4k
Granted 204,000 options to buy
@ $8.52, valued at
$1.7M
|
|
| 01/05/2022 |
4
| ZANTE GREG (CFO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,097 shares
@ $4.88, valued at
$15.1k
Granted 53,333 shares
@ $0
Paid exercise price by delivering 8,835 shares
@ $4.62, valued at
$40.8k
Granted 120,000 options to buy
@ $4.88, valued at
$585.6k
|
|
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|